| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vallon Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 7.5K | $11.4K | $1.52 | Jun 9, 2022 | Direct |
| Arcturus Therapeutics Holdings Inc. | President and CEO, Director | Employee Stock Option (right to buy) | 200K | Dec 15, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ARCT | Arcturus Therapeutics Holdings Inc. | Dec 15, 2023 | 1 | $0 | 4 | Dec 19, 2023 | President and CEO, Director |
| ARCT | Arcturus Therapeutics Holdings Inc. | Dec 9, 2022 | 1 | $0 | 4 | Dec 13, 2022 | President and CEO, Director |
| ARCT | Arcturus Therapeutics Holdings Inc. | Nov 23, 2022 | 1 | $82.6K | 4 | Nov 28, 2022 | President and CEO, Director |
| ARCT | Arcturus Therapeutics Holdings Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | President and CEO, Director |
| GRI | Vallon Pharmaceuticals, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| GRI | Vallon Pharmaceuticals, Inc. | May 25, 2021 | 2 | $71.8K | 4 | May 27, 2021 | Director |
| GRI | Vallon Pharmaceuticals, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |